PDCD1 and melanoma: Further honing in on the importance of the microbiome, a study of 16 melanoma patients who had previously failed to respond to anti-PD-1 therapy received fecal microbiota transplants (FMT) from patients with complete or partial responses to anti-PD-1 treatment.